Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.740
+0.090 (5.45%)
At close: Nov 28, 2025, 1:00 PM EST
1.721
-0.019 (-1.11%)
After-hours: Nov 28, 2025, 4:55 PM EST
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $153.6 million as of November 28, 2025. Its market cap has increased by 539.57% in one year.
Market Cap
153.60M
Enterprise Value
114.64M
1-Year Change
539.57%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $153.60M, a decrease of -40.11%. That is a compound annual growth rate of -11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 153.60M | 427.14% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |